Cargando…

Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425-A1g8

Detalles Bibliográficos
Autores principales:	Yu, X, Duval, M, Lewis, C, Cavacini, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442053/ http://dx.doi.org/10.1186/1742-4690-9-S2-P93

Ejemplares similares

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
por: Teh, Audrey Y-H, et al.
Publicado: (2021)

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability
por: Wallace, Aaron L., et al.
Publicado: (2020)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

Production of Hybrid-IgG/IgA Plantibodies with Neutralizing Activity against Shiga Toxin 1
por: Nakanishi, Katsuhiro, et al.
Publicado: (2013)

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
por: Richards, Angelene F., et al.
Publicado: (2020)

Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
por: Fouda, Genevieve G., et al.
Publicado: (2016)

Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
por: Puligedda, Rama Devudu, et al.
Publicado: (2020)

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration
por: Hu, Yue, et al.
Publicado: (2020)

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
por: Jia, Manxue, et al.
Publicado: (2020)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA/IgA) in an Ex Vivo Infant Digestion Model
por: Lueangsakulthai, Jiraporn, et al.
Publicado: (2020)

Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
por: Sun, Lin, et al.
Publicado: (2021)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

KM55 Monoclonal Antibody and IgA Variant of Proliferative Glomerulonephritis With Monoclonal Ig Deposits
por: Zhang, Minfang, et al.
Publicado: (2020)

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch
por: Li, Jin-pu, et al.
Publicado: (2023)

A Case of Hepatic Glomerulosclerosis with Monoclonal IgA1-κ Deposits
por: Okabayashi, Yusuke, et al.
Publicado: (2018)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection
por: Astronomo, Rena D., et al.
Publicado: (2016)

Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020)

IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease
por: Narimatsu, Yoshiki, et al.
Publicado: (2014)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
por: Song, Xu, et al.
Publicado: (2023)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016)

IgG deposition in IgA nephropathy patients
por: Nasri, Hamid
Publicado: (2013)

Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
por: Fischinger, Stephanie, et al.
Publicado: (2020)

IgG3 constant region GM (γ marker) allotypes could influence the neutralizing potency of anti–SARS-CoV-2 monoclonal antibodies
por: Pandey, Janardan P.
Publicado: (2022)

Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Borochova, Kristina, et al.
Publicado: (2021)

IgA1 protease
por: Mistry, Dippica, et al.
Publicado: (2006)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Hegazy, Salama, et al.
Publicado: (2016)

Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children – multicenter study
por: Mizerska-Wasiak, Małgorzata, et al.
Publicado: (2021)

Pneumococcal IgA1 Protease Subverts Specific Protection By Human IgA1
por: Janoff, Edward N., et al.
Publicado: (2013)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
por: Pisil, Yalcin, et al.
Publicado: (2021)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

R: IgG deposition in IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2013)

The origin of prostate gland-secreted IgA and IgG
por: Silva, Juliete A. F., et al.
Publicado: (2017)

IgA Nephropathy in a Patient with IgG Myeloma
por: Lakshmi, B. Sangeeta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q99s4vqvoq1f012eokmvbofvg0